This article provides a comprehensive guide for researchers and drug development professionals tackling the critical challenge of intra-tumoral heterogeneity in Cancer Stem Cell (CSC) analysis.
This article provides a comprehensive overview of the fibroblast-rich extracellular matrix as a critical physical and immunosuppressive barrier to T cell infiltration in solid tumors.
This article provides a detailed exploration of ATLAS-seq, a powerful single-cell RNA sequencing technology designed to precisely identify and characterize antigen-reactive T cells.
This article provides a comprehensive analysis of the synergistic mechanisms by which Aldehyde Dehydrogenase (ALDH) and ATP-binding cassette (ABC) transporters confer multidrug resistance (MDR) in cancer stem cells (CSCs).
This comprehensive guide provides researchers, scientists, and drug development professionals with an in-depth analysis of the ALDEFLUOR assay.
This article explores the transformative role of artificial intelligence and machine learning in predicting the evolution of treatment resistance in breast cancer.
This article provides a detailed exploration of Adeno-Associated Virus (AAV) vectors as delivery vehicles for CRISPR-Cas9 therapeutics in oncology, tailored for researchers and drug development professionals.
This article provides a comprehensive, evidence-based analysis for researchers and drug developers on the pivotal biological differences and clinical performance of 4-1BB and CD28 costimulatory domains in CAR constructs.
This article provides a detailed examination of 3D tumor organoids as advanced pre-clinical models for high-throughput drug screening (HTS).
This article provides a comprehensive guide for researchers and drug development professionals on 3D in vitro microfluidic models for immune-tumor cell interactions.